 |
|
|
||||||||
|
|
||||||||
|
Dear friends, The staff of the Departments of Oncohematology-16 and -27, Oncology, and Marrow Transplantation together with the parents of our patients thank you for your enormous help and support in buying the lacking drugs for the treatment of children. This help has made it possible for us to survive during the difficult stage in the functioning of our hospital, when the state financing for 2006 had already ended and the financing for 2007 had not yet begun. Virtually all the lacking medicines were bought in time. Unfortunately, we will need your help for a month or two more, because gradual supply of the necessary drugs to our hospital is still slower than needed by our departments. But we cannot stop or interrupt treatment of our patients! Now we need a number of very important drugs that are indispensable to treatment of malignant lesions. The situation is further aggravated by the fact that several patients of the oncohematological departments have lung aspergillosis. Treatment of this complication requires a large amount of Vifend. Without this expensive drug, even patients in remission (as to their oncological disease) will lose their chance of survival, because the uncontrollable fungal infection will make further chemotherapy impossible and thus lead to a relapse of cancer. We have to ask for your support again!
With hope and respect,
|
| For the Department of Marrow Transplantation Glucose 500 ml N 20 // 20 packs Valtrex 500 mg N 10 // 20 packs Diflucan 150 ml N 10 // 20 packs Biseptol tab. // 15 packs Biseptol amp. // 15 packs Vifend per os 200 mg // 5 packs Pentaglobin (Intraglobin) 2.5 g // 20 vials Albumin 20% 50 mg // 20 vials Calcium gluconate N 10 // 10 packs Ursofalk N 50 // 5 packs Zovirax 250 mg inj. // 50 vials Sulperason 2 g // 60 vials Vitamin B6 N 10 // 10 packs Concor 2.5 mg // 3 packs Tavanic 500 mg // 15 vials Mannitol soln. 15% // 10 vials Adalate // 20 vials Mesna 400 mg // 100 vials Oliclinomel 1.5 l // 180 bags Head of the Department of Marrow Transplantation E.V. Skorobogatova |
For the Department of Oncohematology-16 Sulperason 2 g // 100 vials Mesna 400 mg // 100 vials Leucovorin 50 mg // 100 vials Fungizone 50 mg // 100 vials Zovirax 250 mg inj. // 50 vials Cytosar 1000 mg // 50 vials Tavanic 400 mg inj. // 50 vials Vincristine 1 mg // 100 vials Vifend per оs 200 mg // 5 packs Maxipime 1 g // 100 vials Albumin 20% 50 mg // 50 vials Immunoglobulin IV 5 mg // 20 vials Selemycin 500 mg // 100 vials Natulan // 10 vials Oliclinomel 1.5 l // 20 bags 6-Mercaptopurine // 50 packs Zyvox 600 mg // 20 bags Lendacin 1 g // 50 vials Head of the Department of Oncohematology and Chemotherapy
|
| For the Department of Oncohematology-27 Sulperason 2 g // 100 vials Mesna 400 mg // 100 vials Leucovorin 50 mg // 100 vials Fungizone 50 mg // 100 vials Zovirax 250 mg inj. // 50 vials Cytosar 1000 mg // 50 vials Tavanic 400 mg inj. // 50 vials Vincristine 1 mg // 100 vials Vifend per os 200 mg // 5 packs Albumin 20% 50 mg // 50 vials Immunoglobulin IV 5 mg // 20 vials Selemycin 500 mg // 100 vials |
Oliclinomel 1.5 l // 20 bags 6-Mercaptopurine // 50 packs Zyvox 600 mg // 20 bags Lendacin 1 g // 50 vials Head of the Department of Oncohematology-27 N.V. Myakova For the Department of Oncology |
 | |
|
